{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Drug Updates and Approvals: 2015 in Review
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Purpose of Activity
To provide an overview of seven drugs recently approved by the FDA.Learning Objectives
After completing this continuing education activity you will be able to:
- Identify the indications, mechanism of action, and pharmacokinetics for seven new drugs.
- Explain the nursing considerations including dosing, administration, and precautions related to each drug.
Disclosures
The authors and planners have disclosed no potential conflicts, financial or otherwise.
Price:
$21.95
Credits:
- ANCC 2.0 CH / 2.0 APH
- DC - BON 2.0 CH
- KY-BON 2.0 CH
- GA - BON 2.0 CH
Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, #50-1223, Florida Board of Nursing, #50-1223, and Georgia Board of Nursing, #50-1223. Your certificate is valid in all states.
Awarded Advanced Pharmacology Hours
Awarded Advanced Pharmacology Hours
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: NP1215A
Published: Dec 2015
Expires: 12/31/2026
Required Passing Score: 13/18 (72%)
Specialties:
Primary Care